We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 20 for:    SAILS

Prevalence of Sleep Disordered Breathing in a Lung Cancer Screening Cohort (SAILS)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT02687997
First Posted: February 23, 2016
Last Update Posted: September 11, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
LUIS SEIJO MACEIRAS, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
  Purpose
Prospective study of sleep disordered breathing in a lung cancer screening cohort.

Condition Intervention
Sleep Apnea Hypopnea Syndrome COPD Emphysema Lung Cancer Other: poligraphy

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Prevalence of Sleep Apnea in a Lung Cancer Screening Cohort Meeting NLST Criteria

Resource links provided by NLM:


Further study details as provided by LUIS SEIJO MACEIRAS, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz:

Primary Outcome Measures:
  • Prevalence of sleep apnea [ Time Frame: 1 year ]

Enrollment: 282
Study Start Date: February 2016
Study Completion Date: July 31, 2017
Primary Completion Date: July 31, 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Diagnostic
Patients enrolled in lung cancer screening subjected to a sleep study.
Other: poligraphy
Sleep study
No Intervention: Contro
Patients enrolled in lung cancer screening not included in the diagnostic intervention arm

Detailed Description:
The proposed study is a prospective single arm study evaluating the prevalence of sleep disordered breathing in a cohort of lung cancer screening patients.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   55 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age 55-75.
  • > 30 pack years tobacco exposure.
  • Enrolled in lung cancer screening program.

Exclusion Criteria:

  • Inability or unwillingness to undergo a home sleep study.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02687997


Locations
Spain
Fundacion Jimenez Diaz
Madrid, Spain, 28040
Sponsors and Collaborators
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
  More Information

Responsible Party: LUIS SEIJO MACEIRAS, Attending Physician, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
ClinicalTrials.gov Identifier: NCT02687997     History of Changes
Other Study ID Numbers: InsitutoFJD
First Submitted: February 17, 2016
First Posted: February 23, 2016
Last Update Posted: September 11, 2017
Last Verified: September 2017

Additional relevant MeSH terms:
Lung Neoplasms
Sleep Apnea Syndromes
Emphysema
Sleep Apnea, Obstructive
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases
Apnea
Respiration Disorders
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases
Pathologic Processes